Clinical Trial Update: Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

View source ↗

Summary

A completed clinical trial comparing meropenem alone versus meropenem plus a glycopeptide for febrile neutropenia after allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Allogenic Blood Stem Cell Transplantation, Febrile Neutropenia | Status: COMPLETED